Tevogen Bio Stock (NASDAQ:TVGNW)

Ownership Financials Chart

Previous Close

$0.06

52W Range

$0.05 - $0.06

50D Avg

-

200D Avg

-

Market Cap

$241.28M

Avg Vol (3M)

-

Beta

-1.03

Div Yield

-

TVGNW Company Profile

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

17

IPO Date

-

Website

TVGNW Performance

TVGNW Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	-	-	-
Operating Income	$-2.27M	$-13.72M	$-4.62M
Net Income	$-67.33K	$4.41M	$-15.60M
EBITDA	$-2.27M	$-953.08K	$-14.99M
Basic EPS	-	$0.04	$-0.13
Diluted EPS	-	$0.04	$-0.13

Fiscal year ends in Dec 23 | Currency in USD